Speak directly to the analyst to clarify any post sales queries you may have.
10% Free customizationThis report comes with 10% free customization, enabling you to add data that meets your specific business needs.
Rising Geriatric Population is Expanding the Malaysian Eye Drop Market
The geriatric population in Malaysia is rapidly increasing, and this has led to a rise in the demand for eye drops in the country. Eye drops are used to treat a variety of eye-related problems, such as dry eyes, allergies, and infections. As people age, their eyes become more vulnerable to various diseases, such as cataracts, glaucoma, and macular degeneration. These conditions can cause vision loss and impair quality of life. Eye drops are an effective way to manage these conditions, and they are becoming increasingly popular among the elderly population in Malaysia. Another factor contributing to the rise in demand for eye drops in Malaysia is the increasing prevalence of diabetes. Diabetes can cause a range of eye problems, such as diabetic retinopathy, which can lead to blindness if left untreated. According to the National Health and Morbidity Survey 2019, in Malaysia, type 2 diabetes (T2D) prevalence has increased to 20.8% in persons over the age of 30, affecting 2.8 million people. As the number of diabetics in Malaysia increases, so does the demand for eye drops to manage their eye-related complications. According to the Department of Statistics Malaysia (DoSM), the proportion of Malaysia's population over the age of 65 increased as well, from 5% in 2010 to 6.8% in 2020 and by 2050, more than 15% of Malaysia's population would be over the age of 65.Rising Prevalence of Eye Diseases is Booming the Malaysia Eye Drop Market
In recent years, Malaysia has seen a rise in the prevalence of eye diseases, with an increasing number of individuals suffering from eye-related problems such as cataracts, glaucoma, dry eye syndrome, and age-related macular degeneration (AMD). This rise in the incidence of eye diseases has led to a corresponding boom in the Malaysia eye drop market as individuals seek out products that can help alleviate their symptoms and maintain good eye health. One of the major drivers of the Malaysia eye drop market is the increasing incidence of cataracts, which is a leading cause of blindness in the country. According to the National Library of Medicines, in 2022, the prevalence of cataract among older people was 26.8%. Glaucoma is another eye disease that is becoming increasingly prevalent in Malaysia. The condition is often referred to as the "silent thief of sight" as it often progresses slowly and without symptoms, until significant vision loss occurs. As a result, early detection and treatment are critical in preventing vision loss from glaucoma, and many individuals turn to eye drops as a first line of defense, leading to the rise I demand for the Malaysia eye drop market. Dry eye syndrome is yet another condition that is on the rise in Malaysia, particularly among those who spend long hours working on computers or smartphones. The condition is characterized by a lack of lubrication on the surface of the eye, which can cause discomfort, redness, and blurred vision. Eye drops containing artificial tears are often used to alleviate these symptoms. Age-related macular degeneration (AMD) is also becoming more prevalent in Malaysia, particularly as the population ages. The condition is a leading cause of vision loss in individuals over the age of 60, and while there is no cure, there are several treatments available, including eye drops that can help slow the progression of the disease. In response to the rising prevalence of eye diseases, the Malaysia eye drop market has become increasingly competitive, with a wide range of products now available to suit different needs, these companies offer a range of eye drops targeting various conditions, including dry eye, glaucoma, and cataracts. The Malaysia eye drop market is highly competitive, with both local and international players competing for market share leading to the growth of the Malaysian eye drop market.Market Segmentation
Malaysia eye drop market is segmented into type, drug class, disease indication, distribution channel, region, and company. Based on type, Malaysia eye drop market is divided into prescription and over the counter. Based on drug class, Malaysia eye drop market is categorized into antiallergy, anti-inflammatory, antiglaucoma, anti-VEGF, and others. Based on disease indication, Malaysia eye drop market is categorized into dry eye diseases, glaucoma, eye allergy, eye infections, retinal disorders, and others. Based on distribution channel, Malaysia eye drop market is categorized into hospitals pharmacy, retail pharmacy, and online pharmacy. Based on region, the Malaysia eye drop market is segmented into the East Malaysia and West Malaysia.Company Profiles
Alcon Laboratories (Malaysia) Sdn Bhd, Johnson & Johnson, CooperVision Contact Lens Malaysia Sdn Bhd, Metro optical Group Eyeware, TRB CHEMEDICA, Xepa Laboratories Pte. Ltd, Thea Pharma Sdn Bhd, Systane, and Rohto are some of the key players of Malaysia eye drop market.Report Scope:
In this report, the Malaysia eye drop market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:Malaysia Eye Drop Market, By Type:
- Prescription
- Over the Counter
Malaysia Eye Drop Market, By Drug Class:
- Antiallergy
- Anti-inflammatory
- Antiglaucoma
- Anti-VEGF
- Others
Malaysia Eye Drop Market, By Disease Indication:
- Dry Eye Diseases
- Glaucoma
- Eye Allergy
- Eye Infections
- Retinal Disorders
- Others
Malaysia Eye Drop Market, By Distribution Channel:
- Hospitals Pharmacy
- Retail Pharmacy
- Online Pharmacy
Malaysia Eye Drop Market, By Region:
- The East Malaysia
- The West Malaysia
Competitive landscape
Company Profiles: Detailed analysis of the major companies in Malaysia eye drop market.Available Customizations:
With the given market data, the publisher offers customizations according to a company’s specific needs.This product will be delivered within 1-3 business days.
Table of Contents
Companies Mentioned
- Alcon Laboratories (Malaysia) Sdn Bhd
- Johnson & Johnson
- CooperVision Contact Lens Malaysia Sdn Bhd
- Metro optical Group Eyeware
- TRB CHEMEDICA
- Xepa Laboratories Pte. Ltd
- Thea Pharma Sdn Bhd
- Systane
- Rohto